Nathan, P., Hassel, J. C., Rutkowski, P., Baurain, J.-F., Butler, M. O., Schlaak, M., Sullivan, R. J., Ochsenreither, S., Dummer, R., Kirkwood, J. M., Joshua, A. M., Sacco, J. J., Shoushtari, A. N., Orloff, M., Piulats, J. M., Milhem, M., Salama, A. K. S., Curti, B., Demidov, L., … Piperno-Neumann, S. (2021). Overall Survival Benefit with Tebentafusp in Metastatic Uveal Melanoma. New England Journal of Medicine, 385(13), 1196–1206. https://doi.org/10.1056/nejmoa2103485
Subjects:
Ocular Cancer Research and Treatment
(OpenAlex Topic)
Immunobiology of Dendritic Cells
(OpenAlex Topic)
Gene Therapy Techniques and Applications
(OpenAlex Topic)
Antineoplastic Agents
(MeSH)
Melanoma
(MeSH)
Recombinant Fusion Proteins
(MeSH)
Uveal Neoplasms
(MeSH)
Publication Type:
Article
Unique ID:
10.1056/nejmoa2103485
PMID:
Journal:
Publication Date:
Data Source:
PubMed